Home
Scholarly Works
A dose-escalation phase I study of a...
Conference

A dose-escalation phase I study of a first-in-class cancer stemness inhibitor in patients with advanced malignancies

Authors

Langleben A; Supko JG; Hotte SJ; Batist G; Hirte HW; Rogoff H; Li Y; Li W; Kerstein D; Leggett D

Volume

31

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

May 20, 2013

Name of conference

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference place

IL, Chicago

Conference start date

May 31, 2013

Conference end date

June 4, 2013

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

15

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team